Led by David Liljenquist, MD, the TrialNet team at Rocky Mountain Diabetes and Osteoporosis Center is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Rocky Mountain Diabetes and Osteoporosis Center is regionally overseen by Benaroya Research Institute. If you reach out to TrialNet, you may be contacted by staff from either institution.